Formosa Pharmaceuticals (台新藥) is a clinical stage biopharmaceutical company with primary focus in ophthalmology and oncology.
Our flagship asset, APP13007 (Clobetasol Propionate ophthalmic suspension 0.05%) was recently approved by the US FDA (March, 2024) for the treatment of post-operative inflammation and pain following ocular surgery.
In August, 2017, Formosa Pharmaceuticals completed the acquisition of Activus Pharma, based in Funabashi, Japan. With the acquisition of the Activus Pure Nanoparticle Technology (APNT) Platform, Formosa Pharmaceuticals enters the ophthalmology disease area with two late-preclinical assets and the goal of expanding the platform’s scope and application. APNT effectively reduces API particle size to improve dissolution and bioavailability without the drawbacks of heavy metal contamination other platforms often experience.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 8f-6 No. 57 Fuxing North Road, Songshan District,taipei City 105,taiwan, Province Of China
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- formosapharma.com
- HQ
- Songshan District, Taipei City
Formosa Pharmaceuticals, Inc. Questions
Formosa Pharmaceuticals, Inc.'s website is formosapharma.com
Formosa Pharmaceuticals, Inc.'s LinkedIn profile is https://is.linkedin.com/company/formosa-pharmaceuticals
Formosa Pharmaceuticals, Inc. has
15 employees.
View email and phone details for 15
employees at Formosa Pharmaceuticals, Inc..
Formosa Pharmaceuticals, Inc.'s industry is
Pharmaceutical Manufacturing
Formosa Pharmaceuticals, Inc.'s top competitors are
Bora Pharmaceuticals,
Dávi - Farmacêutica,
Formosa Laboratories, Inc.,
Scinopharm Taiwan Ltd,
Obi Pharma,
Apotex Inc.,
Mycenax Biotech Inc.,
Eyenovia, Inc.,
Harrow,
Aimmax Therapeutics, Inc..
Formosa Pharmaceuticals, Inc.'s categories are Pharmaceutical Manufacturing
Formosa Pharmaceuticals, Inc.'s founding year is 2010
